| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |